Henan Cancer Hospital

This study tested whether adding lenalidomide to standard chemotherapy (R-CHOP) helps people with a fast-growing type of lymphoma called diffuse large B-cell lymphoma. 60 adults with medium-to-high risk disease took part. The goal was to see if the combination improves how long p…

This study tested a combination of two drugs (durvalumab and anlotinib) plus standard chemotherapy as a first treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer. The goal was to see if this triple therapy could delay cancer growth better than …

This study tested a pill called hetrombopag in 60 people with advanced breast cancer who had low platelets from chemotherapy. The goal was to see if the drug could safely raise platelet levels and reduce the need for platelet transfusions or chemo delays. Results will help guide …

This study tested a combination of two drugs (toripalimab and gemcitabine) given before surgery to people with muscle-invasive bladder cancer who cannot take the standard chemotherapy drug cisplatin. The goal was to see how well the drugs shrink tumors before the bladder is remov…

This study tested a combination of drugs called VR-CAP as a first treatment for people with marginal zone lymphoma, a type of blood cancer. 26 patients received the therapy to see how well it controlled the disease and how safe it was. The main goal was to measure how many patien…